Embecta Corp. - Common Stock (NQ:EMBC)

6.550 -0.250 (-3.68%)

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Embecta Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

embecta to Report Fiscal First Quarter 2025 Financial Results

January 23, 2025

From Embecta Corp.

Via GlobeNewswire

Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 14, 2025

Via Benzinga

Topics Government

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

December 19, 2024

From Embecta Corp.

Via GlobeNewswire

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

Uncovering Potential: Embecta's Earnings Preview ↗

November 25, 2024

Via Benzinga

This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday ↗

November 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views ↗

November 26, 2024

Via Benzinga

Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps ↗

November 26, 2024

Embecta reports fourth quarter earnings beating estimates, discontinues insulin patch program, and announces restructuring plans with cost-saving measures.

Via Benzinga

Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results ↗

November 26, 2024

Via Benzinga

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

November 26, 2024

Via Benzinga

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

November 26, 2024

From Embecta Corp.

Via GlobeNewswire

embecta Announces Quarterly Cash Dividend

November 26, 2024

From Embecta Corp.

Via GlobeNewswire

Earnings Scheduled For November 26, 2024 ↗

November 26, 2024

Via Benzinga

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

November 12, 2024

From Embecta Corp.

Via GlobeNewswire

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

November 12, 2024

From Embecta Corp.

Via GlobeNewswire

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

November 07, 2024

Advocacy and professional groups join global diabetes care company at Nasdaq to raise awareness of diabetes, while also commemorating the company’s 100-year legacy of serving this community

From Embecta Corp.

Via GlobeNewswire

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

September 03, 2024

From Embecta Corp.

Via GlobeNewswire

embecta to Participate in Investor Events

August 22, 2024

From Embecta Corp.

Via GlobeNewswire

EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024 ↗

August 09, 2024

EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

August 09, 2024

From Embecta Corp.

Via GlobeNewswire

embecta Announces Quarterly Cash Dividend

August 09, 2024

From Embecta Corp.

Via GlobeNewswire

Insulin Device Maker Embecta Weighs Sale After 70% Share Decline Following Becton Dickinson Spin-Off ↗

July 23, 2024

Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The company's U.S. business has struggled with the rise of GLP-1 drugs and...

Via Benzinga

Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 22, 2024

Via Benzinga

IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday ↗

July 22, 2024

Via Benzinga

embecta to Report Fiscal Third Quarter 2024 Financial Results

July 18, 2024

From Embecta Corp.

Via GlobeNewswire

Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday ↗

July 11, 2024

Via Benzinga

embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

June 24, 2024

From Embecta Corp.

Via GlobeNewswire

Trade Winds Turning: 3 Stocks Poised to Gain from Biden’s China Tariffs ↗

May 21, 2024

Here are three potential stocks to buy that could benefit from China tariffs amidst the turning trade winds.

Via InvestorPlace

Topics World Trade

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 09, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.